Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease
Objective: DUX4 is an embryonic transcription factor (TF) later silenced in somatic tissues, while active in germline testis cells. Re-expression in somatic cells has been revealed to be present in pathologic conditions such as dystrophy, leukemia, and other cancer types. Embryonic cells, cancer cel...
Saved in:
Main Authors: | Ceren HANGUL (Author), Oznur TOKTA (Author), Sibel BERKER KARAUZUM (Author), Bahar AKKAYA (Author), Hulya YILDIRIM (Author), Funda TAYFUN KUPESIZ (Author), Ayse Nur AKINEL (Author) |
---|---|
Format: | Book |
Published: |
Federation of Turkish Pathology Societies,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Designed U7 snRNAs inhibit DUX4 expression and improve FSHD-associated outcomes in DUX4 overexpressing cells and FSHD patient myotubes
by: Afrooz Rashnonejad, et al.
Published: (2021) -
DUX4 expression activates JNK and p38 MAP kinases in myoblasts
by: Christopher M. Brennan, et al.
Published: (2022) -
A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy
by: Virginie Mariot, et al.
Published: (2020) -
Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy
by: Linde F. Bouwman, et al.
Published: (2021) -
RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy
by: Virginie Mariot, et al.
Published: (2021)